InsiderTrades.com logo

CRNX Insider Trading

Insider Ownership Percentage: 4.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $7,854,502.84

Crinetics Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Crinetics Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Crinetics Pharmaceuticals Share Price & Price History

Current Price: $35.07
Price Change: ▼ Price Decrease of -1.242 (-3.42%)
As of 03/27/2026 12:07 PM ET

This chart shows the closing price history over time for CRNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2026Jeff E. KnightCOOSell9,911$37.37$370,374.07112,018View SEC Filing Icon  
3/16/2026Richard Scott StruthersCEOSell21,981$37.37$821,429.97404,778View SEC Filing Icon  
3/16/2026Stephen F. BetzInsiderSell10,612$37.37$396,570.44137,101View SEC Filing Icon  
3/12/2026Coelho Rogerio VivaldiDirectorSell5,000$36.15$180,750.0016,300View SEC Filing Icon  
3/3/2026Stephanie OkeyDirectorSell3,000$39.67$119,010.0013,300View SEC Filing Icon  
3/3/2026Tobin SchilkeCFOSell6,713$39.67$266,304.7178,121View SEC Filing Icon  
1/5/2026Isabel KalofonosInsiderSell2,500$55.00$137,500.00834View SEC Filing Icon  
11/3/2025Dana PizzutiInsiderSell5,000$42.66$213,300.0066,270View SEC Filing Icon  
10/1/2025Dana PizzutiInsiderSell5,000$41.81$209,050.0066,270View SEC Filing Icon  
9/26/2025Matthew K. FustDirectorSell16,000$44.75$716,000.0022,836View SEC Filing Icon  
9/26/2025Richard Scott StruthersCEOSell4,000$45.00$180,000.00106,000View SEC Filing Icon  
8/22/2025Dana PizzutiInsiderSell30,000$30.43$912,900.0066,270View SEC Filing Icon  
8/20/2025Dana PizzutiInsiderSell6,492$29.18$189,436.5666,270View SEC Filing Icon  
6/12/2025Stephen F. BetzInsiderSell97,483$32.23$3,141,877.0999,713View SEC Filing Icon  
3/19/2025Dana PizzutiInsiderSell2,515$34.20$86,013.0072,233View SEC Filing Icon  
3/19/2025Jeff E. KnightCOOSell7,162$34.20$244,940.4087,491View SEC Filing Icon  
3/19/2025Richard Scott StruthersCEOSell17,338$34.20$592,959.60329,147View SEC Filing Icon  
2/3/2025Dana PizzutiInsiderSell5,000$39.07$195,350.0031,748View SEC Filing Icon  
11/22/2024Jeff E. KnightCOOSell501$56.52$28,316.5251,653View SEC Filing Icon  
10/3/2024Dana PizzutiInsiderSell14,375$54.63$785,306.2528,507View SEC Filing Icon  
9/26/2024Marc WilsonCFOSell25,000$51.11$1,277,750.00111,092View SEC Filing Icon  
9/10/2024Stephen F. BetzInsiderSell1,035$51.50$53,302.5068,576View SEC Filing Icon  
8/26/2024Stephen F. BetzInsiderSell3,000$53.19$159,570.0069,611View SEC Filing Icon  
7/25/2024Marc WilsonCFOSell19,056$53.88$1,026,737.28111,092View SEC Filing Icon  
7/25/2024Stephen F. BetzInsiderSell3,000$53.43$160,290.0075,611View SEC Filing Icon  
7/15/2024Jeff E. KnightCOOSell27,000$55.00$1,485,000.0051,653View SEC Filing Icon  
7/15/2024Marc WilsonCFOSell25,000$55.00$1,375,000.00111,092View SEC Filing Icon  
7/10/2024Stephen F. BetzInsiderSell3,000$48.55$145,650.0078,611View SEC Filing Icon  
7/5/2024James HassardInsiderSell15,000$44.08$661,200.0029,259View SEC Filing Icon  
7/3/2024Dana PizzutiInsiderSell14,375$44.87$645,006.2528,507View SEC Filing Icon  
6/28/2024Marc WilsonCFOSell32,129$43.61$1,401,145.69111,092View SEC Filing Icon  
6/26/2024Jeff E. KnightCOOSell956$44.38$42,427.2852,580View SEC Filing Icon  
6/24/2024Dana PizzutiInsiderSell9,500$45.73$434,435.0027,786View SEC Filing Icon  
6/21/2024James HassardInsiderSell15,000$44.66$669,900.0029,259View SEC Filing Icon  
6/10/2024Stephen F. BetzInsiderSell3,000$43.86$131,580.0083,643View SEC Filing Icon  
5/28/2024Stephen F. BetzInsiderSell3,000$47.49$142,470.0086,643View SEC Filing Icon  
5/10/2024Stephen F. BetzInsiderSell3,000$49.43$148,290.0089,643View SEC Filing Icon  
5/8/2024Richard Scott StruthersCEOSell107,448$49.40$5,307,931.20257,485View SEC Filing Icon  
4/15/2024Dana PizzutiInsiderSell14,375$44.47$639,256.2527,786View SEC Filing Icon  
4/4/2024Richard Scott StruthersCEOSell40,951$49.17$2,013,560.67237,835View SEC Filing Icon  
3/28/2024Stephanie OkeyDirectorSell17,500$46.38$811,650.006,000View SEC Filing Icon  
3/22/2024Jeff E. KnightCOOSell32,359$44.31$1,433,827.2952,580View SEC Filing Icon  
3/20/2024Dana PizzutiInsiderSell15,089$44.06$664,821.3427,786View SEC Filing Icon  
3/20/2024Matthew K. FustDirectorSell60,000$44.14$2,648,400.0018,536View SEC Filing Icon  
3/19/2024Marc WilsonCFOSell6,942$42.91$297,881.22110,630View SEC Filing Icon  
1/25/2024Stephen F. BetzInsiderSell3,000$37.26$111,780.0073,298View SEC Filing Icon  
1/10/2024Stephen F. BetzInsiderSell3,000$37.65$112,950.0076,298View SEC Filing Icon  
1/3/2024Dana PizzutiInsiderSell14,375$35.00$503,125.005,911View SEC Filing Icon  
1/2/2024Marc WilsonCFOSell10,000$35.47$354,700.0096,055View SEC Filing Icon  
12/26/2023Stephen F. BetzInsiderSell3,000$35.89$107,670.0079,298View SEC Filing Icon  
12/21/2023Dana PizzutiInsiderSell9,583$34.57$331,284.315,911View SEC Filing Icon  
12/11/2023Stephen F. BetzInsiderSell3,000$32.87$98,610.0082,298View SEC Filing Icon  
11/27/2023Stephen F. BetzInsiderSell3,000$31.84$95,520.0085,298View SEC Filing Icon  
11/3/2023Richard Scott StruthersCEOSell199,082$30.56$6,083,945.92135,522View SEC Filing Icon  
11/1/2023Marc WilsonCFOSell10,000$28.75$287,500.0095,601View SEC Filing Icon  
10/17/2023Alan Seth KrasnerInsiderSell7,000$30.00$210,000.0043,210View SEC Filing Icon  
7/13/2023Richard Scott StruthersCEOSell14,157$20.35$288,094.95630,805View SEC Filing Icon  
7/11/2023Richard Scott StruthersCEOSell24,384$20.14$491,093.76656,421View SEC Filing Icon  
6/20/2023Marc WilsonCFOSell30,922$19.97$617,512.3495,158View SEC Filing Icon  
6/16/2023Richard Scott StruthersCEOSell50,000$20.81$1,040,500.00680,805View SEC Filing Icon  
6/8/2023Coelho Rogerio VivaldiDirectorBuy5,000$22.06$110,300.005,000View SEC Filing Icon  
4/5/2023Dana PizzutiInsiderSell8,212$16.15$132,623.804,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

98.51% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Crinetics Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.4,679$0.22M0.0%+12.5%0.004%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.59,121$2.75M0.0%-2.4%0.058%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.158,089$7.36M0.0%+76.8%0.155%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp5,666$0.27M0.0%-4.6%0.006%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC309,368$14.40M1.1%+24.6%0.303%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC13,535$0.63M0.2%+282.7%0.013%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP8,037,889$374.16M0.1%-4.1%7.867%Search for SEC Filing on Google Icon
2/18/2026Progeny 3 Inc.24,000$1.12M0.1%N/A0.023%Search for SEC Filing on Google Icon
2/18/2026RTW Investments LP1,351,326$62.90M0.6%+54.9%1.323%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC15,848$0.74M0.5%N/A0.016%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC300,335$13.98M0.0%+38.9%0.294%Search for SEC Filing on Google Icon
2/18/2026Man Group plc62,560$2.91M0.0%N/A0.061%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC4,440,691$206.60M0.1%+15.1%4.346%Search for SEC Filing on Google Icon
2/18/2026Cormorant Asset Management LP300,000$13.97M0.6%-25.0%0.294%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.233,197$10.86M0.0%+1,560.4%0.228%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP1,648,869$76.76M0.4%+488.9%1.614%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC309,368$14.40M1.0%+24.6%0.303%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers4,810$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026First Light Asset Management LLC1,194,263$55.59M4.3%+26.8%1.169%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP2,210,774$102.91M2.6%-13.3%2.164%Search for SEC Filing on Google Icon
2/17/2026Amundi5,622$0.26M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Farallon Capital Management LLC6,933,098$322.74M1.5%+20.2%6.786%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD5,224,387$243.20M0.0%-1.5%5.113%Search for SEC Filing on Google Icon
2/17/2026T. Rowe Price Investment Management Inc.29,085$1.35M0.0%-52.0%0.028%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System85,568$3.98M0.0%+1.7%0.084%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.119,905$5.58M0.0%-19.5%0.117%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board55,561$2.59M0.0%-2.6%0.054%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada47,295$2.20M0.0%-72.3%0.046%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC171,830$8M0.4%-1.3%0.168%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC8,524$0.40M0.0%+13.9%0.008%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC5,394$0.25M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/16/2026Arax Advisory Partners1,498$70K0.0%+131.2%0.001%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC185,677$8.64M0.0%+1.3%0.182%Search for SEC Filing on Google Icon
2/13/2026Prosight Management LP262,904$12.24M2.5%-20.0%0.257%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC2,922$0.14M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 148,489$7M0.0%+0.5%0.145%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co8,214$0.38M0.0%-63.6%0.008%Search for SEC Filing on Google Icon
2/13/2026Segall Bryant & Hamill LLC189,477$8.82M0.1%+4.8%0.185%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC4,931$0.23M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp21,200$0.99M0.0%-2.5%0.021%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank8,019$0.37M0.0%+5.9%0.008%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC639$30K0.0%+107.5%0.001%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group187,433$8.88M0.0%+114.7%0.183%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC4,865$0.23M0.0%-21.3%0.005%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP33,150$1.54M0.0%+378.3%0.032%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC23,217$1.08M0.1%+14.9%0.023%Search for SEC Filing on Google Icon
2/13/2026Siren L.L.C.1,507,636$70.18M2.1%-10.7%1.476%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.781,981$36.40M0.0%+0.4%0.765%Search for SEC Filing on Google Icon
2/13/2026State Street Corp2,161,378$100.61M0.0%-2.1%2.115%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC225,842$10.51M0.0%+3.7%0.221%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN139,461$6.49M0.0%+41.3%0.136%Search for SEC Filing on Google Icon
2/13/2026Castleark Management LLC62,790$2.92M0.1%N/A0.061%Search for SEC Filing on Google Icon
2/12/2026Brooklyn Investment Group5,890$0.28M0.0%+6.3%0.006%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC30,495$1.42M0.0%+80.9%0.030%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC49,818$2.32M0.0%-6.7%0.049%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp5,982$0.28M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP548,977$25.56M0.0%+45.3%0.537%Search for SEC Filing on Google Icon
2/12/2026Decheng Capital LLC92,700$4.32M0.6%-35.2%0.091%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc275,616$12.83M0.0%-6.6%0.270%Search for SEC Filing on Google Icon
2/12/2026Skandinaviska Enskilda Banken AB publ 213,891$9.96M0.0%+19.8%0.209%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund146,123$6.80M0.0%-1.5%0.143%Search for SEC Filing on Google Icon
2/12/2026Sector Gamma AS115,000$5.35M1.2%N/A0.113%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.77,765$3.62M0.0%+64.0%0.076%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank176,500$8.22M0.0%+2.3%0.173%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC522,466$24.32M0.0%-4.1%0.511%Search for SEC Filing on Google Icon
2/11/2026Meeder Advisory Services Inc.4,646$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG235,018$10.94M0.0%+1.1%0.230%Search for SEC Filing on Google Icon
2/11/2026GW&K Investment Management LLC1,476,325$68.72M0.6%+73.6%1.445%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC18,974$0.88M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC6,154$0.29M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.17,671$0.82M0.0%-13.4%0.017%Search for SEC Filing on Google Icon
2/11/2026Fiera Capital Corp578,455$26.93M0.1%+32.8%0.566%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.1,154,710$53.75M0.0%-8.3%1.130%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC11,267$0.49M0.0%+19.4%0.011%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd28,384$1.32M0.0%-58.4%0.028%Search for SEC Filing on Google Icon
2/11/2026Parallel Advisors LLC1,225$57K0.0%+34.6%0.001%Search for SEC Filing on Google Icon
2/11/2026Arrowpoint Investment Partners Singapore Pte. Ltd.4,717$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming669$31K0.0%-31.5%0.001%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc190,478$8.87M0.0%-6.4%0.186%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.567,127$26.40M0.0%-20.5%0.555%Search for SEC Filing on Google Icon
2/10/2026Natixis Advisors LLC20,035$0.93M0.0%-61.3%0.020%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC30,243$1.41M0.0%+36.1%0.030%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC2,242,631$104.41M0.0%-1.6%2.195%Search for SEC Filing on Google Icon
2/9/2026Fisher Asset Management LLC758,659$35.32M0.0%+0.0%0.743%Search for SEC Filing on Google Icon
2/9/2026Legal & General Group Plc87,802$4.09M0.0%-6.4%0.086%Search for SEC Filing on Google Icon
2/9/2026Lisanti Capital Growth LLC43,040$2M0.5%+88.0%0.042%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC16,035$0.75M0.1%+182.1%0.016%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC11,316$0.53M0.5%N/A0.011%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.5,270$0.25M0.0%-11.5%0.005%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB29,500$1.37M0.0%-8.1%0.029%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC20,721$0.97M0.0%+10.2%0.020%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS16,089$0.75M0.0%+75.7%0.016%Search for SEC Filing on Google Icon
2/5/2026Baader Bank Aktiengesellschaft8,625$0.40M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/5/2026HighMark Wealth Management LLC21,495$1M0.4%+7.5%0.021%Search for SEC Filing on Google Icon
2/2/2026Truist Financial Corp9,879$0.46M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio5,300$0.25M0.0%+341.7%0.005%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.5,973$0.28M0.0%+14.9%0.006%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer Asset Management Inc.17,786$0.83M0.0%+235.8%0.017%Search for SEC Filing on Google Icon
1/30/2026Jennison Associates LLC1,281,601$59.66M0.0%-37.3%1.351%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D30,537$1.42M0.0%-57.8%0.032%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Crinetics Pharmaceuticals logo
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Crinetics Pharmaceuticals

Today's Range

Now: $35.07
Low: $34.79
High: $36.34

50 Day Range

MA: $43.94
Low: $34.37
High: $55.99

52 Week Range

Now: $35.07
Low: $24.10
High: $57.99

Volume

226,706 shs

Average Volume

1,260,496 shs

Market Capitalization

$3.67 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.23

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top insider investors include:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Richard Scott Struthers (CEO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Marc Wilson (CFO)
  6. Tobin Schilke (CFO)
  7. Dana Pizzuti (Insider)
  8. Alan Seth Krasner (Insider)
  9. James Hassard (Insider)
  10. Matthew K Fust (Director)
Learn More about top insider investors at Crinetics Pharmaceuticals.

Who are the major institutional investors of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 9.63%
  2. Wellington Management Group LLP — 7.87%
  3. Farallon Capital Management LLC — 6.79%
  4. Price T Rowe Associates Inc. MD — 5.11%
  5. Janus Henderson Group PLC — 4.35%
  6. Geode Capital Management LLC — 2.20%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.

Which institutional investors are selling Crinetics Pharmaceuticals stock?

During the previous quarter, CRNX stock was sold by these institutional investors:
  1. Jennison Associates LLC
  2. Wellington Management Group LLP
  3. Paradigm Biocapital Advisors LP
  4. Siren L.L.C.
  5. Goldman Sachs Group Inc.
  6. Royal Bank of Canada
  7. JPMorgan Chase & Co.
  8. Cormorant Asset Management LP
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
  1. Perceptive Advisors Llc (Major Shareholder)
  2. Richard Scott Struthers (CEO)
  3. Stephen F Betz (Insider)
  4. Jeff E Knight (COO)
  5. Marc Wilson (CFO)
  6. Tobin Schilke (CFO)
  7. Dana Pizzuti (Insider)
  8. Alan Seth Krasner (Insider)
  9. James Hassard (Insider)
Learn More investors selling Crinetics Pharmaceuticals stock.

Which institutional investors are buying Crinetics Pharmaceuticals stock?

In the last quarter, CRNX stock was bought by institutional investors including:
  1. Baker BROS. Advisors LP
  2. Farallon Capital Management LLC
  3. GW&K Investment Management LLC
  4. Janus Henderson Group PLC
  5. UBS Group AG
  6. RTW Investments LP
  7. Ikarian Capital LLC
  8. Aberdeen Group plc

Crinetics Pharmaceuticals Active Insiders

Richard Scott Struthers
Richard Scott Struthers
CEO
1 recent trades
Jeff E Knight
COO
1 recent trades
Marc Wilson
CFO
Tobin Schilke
Tobin Schilke
Chief Financial Officer
1 recent trades
Matthew K Fust
Matthew K Fust (Age 60)
Director
Stephanie Okey
Stephanie Okey
Director
1 recent trades
Coelho Rogerio Vivaldi
Coelho Rogerio Vivaldi
Director
1 recent trades
James Hassard
James Hassard
Chief Commercial Officer
Dana Pizzuti
Dana Pizzuti
Chief Medical and Development Officer
2 recent trades
Alan Seth Krasner
Alan Seth Krasner
Chief Endocrinologist
Stephen F Betz
Stephen F Betz (Age 60)
Insider
1 recent trades
Ajay Madan
Ajay Madan (Age 57)
Insider